Frédéric Eberlé

411 total citations
9 papers, 363 citations indexed

About

Frédéric Eberlé is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, Frédéric Eberlé has authored 9 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Cardiology and Cardiovascular Medicine and 3 papers in Immunology. Recurrent topics in Frédéric Eberlé's work include Viral gastroenteritis research and epidemiology (2 papers), Viral Infections and Immunology Research (2 papers) and interferon and immune responses (2 papers). Frédéric Eberlé is often cited by papers focused on Viral gastroenteritis research and epidemiology (2 papers), Viral Infections and Immunology Research (2 papers) and interferon and immune responses (2 papers). Frédéric Eberlé collaborates with scholars based in France and Switzerland. Frédéric Eberlé's co-authors include Patrice Dubreuil, Marie‐Geneviève Mattéi, Marc Lopez, Élisabeth Devilard, Françoise Birg, Jean Gabert, Florence Bardin, Sophie Gomez, G. Adler and Frédérique Nowak and has published in prestigious journals such as Blood, Gene and Leukemia & lymphoma.

In The Last Decade

Frédéric Eberlé

9 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frédéric Eberlé France 6 136 125 85 83 60 9 363
Chandra Somasundaram United States 11 128 0.9× 68 0.5× 71 0.8× 47 0.6× 56 0.9× 44 422
Katie M. Stiles United States 14 143 1.1× 150 1.2× 36 0.4× 94 1.1× 84 1.4× 18 488
Susana Barroso Spain 7 110 0.8× 44 0.4× 71 0.8× 54 0.7× 28 0.5× 9 326
Klaus Mannweiler Germany 9 132 1.0× 114 0.9× 20 0.2× 51 0.6× 62 1.0× 10 379
Rhianna S. Sundsbak United States 13 183 1.3× 66 0.5× 89 1.0× 211 2.5× 32 0.5× 14 563
Allan R. Sinning United States 13 215 1.6× 70 0.6× 36 0.4× 86 1.0× 70 1.2× 25 423
P N Tsichlis United States 11 234 1.7× 90 0.7× 34 0.4× 155 1.9× 128 2.1× 12 465
Pierre Dehan Belgium 13 232 1.7× 25 0.2× 55 0.6× 49 0.6× 43 0.7× 18 594
Sandrine Alais France 16 444 3.3× 36 0.3× 36 0.4× 276 3.3× 26 0.4× 25 720
Camilo Raggo Canada 11 207 1.5× 236 1.9× 16 0.2× 152 1.8× 56 0.9× 11 627

Countries citing papers authored by Frédéric Eberlé

Since Specialization
Citations

This map shows the geographic impact of Frédéric Eberlé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Eberlé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Eberlé more than expected).

Fields of papers citing papers by Frédéric Eberlé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Eberlé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Eberlé. The network helps show where Frédéric Eberlé may publish in the future.

Co-authorship network of co-authors of Frédéric Eberlé

This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric Eberlé. A scholar is included among the top collaborators of Frédéric Eberlé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric Eberlé. Frédéric Eberlé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Landais, Paul, Valérie Méresse, Arnaud Olivier, et al.. (2009). Evaluation and Validation of Diagnostic Tests for Guiding Therapeutic Decisions. Therapies. 64(3). 195–201. 8 indexed citations
2.
Landais, Paul, Valérie Méresse, Arnaud Olivier, et al.. (2009). Évaluation et validation des tests diagnostiques dans le cadre du ciblage thérapeutique. Therapies. 64(3). 187–194. 5 indexed citations
3.
Dubreuil, Patrice, et al.. (2000). Capture of cytokine-responsive genes (NACA and RBM3) using a gene trap approach. Blood. 95(12). 3750–3757. 9 indexed citations
4.
Dubreuil, Patrice, et al.. (2000). Capture of cytokine-responsive genes (NACA and RBM3) using a gene trap approach. Blood. 95(12). 3750–3757. 17 indexed citations
5.
Lopez, Marc, Frédéric Eberlé, Marie‐Geneviève Mattéi, et al.. (1995). Complementary DNA characterization and chromosomal localization of a human gene related to the poliovirus receptor-encoding gene. Gene. 155(2). 261–265. 150 indexed citations
6.
Eberlé, Frédéric, Yves Toiron, Jacques Camerlo, et al.. (1995). Persistence of BCR/ABL mRNA-Expressing Bone-Marrow Cells in Patients with Chronic Myelogenous Leukemia in Complete Cytogenetic Remission Induced by Interferon-alpha Therapy. Leukemia & lymphoma. 18(1-2). 153–157. 2 indexed citations
7.
Eberlé, Frédéric, Patrice Dubreuil, Marie‐Geneviève Mattéi, Élisabeth Devilard, & Marc Lopez. (1995). The human PRR2 gene, related to the human poliovirus receptor gene (PVR), is the true homolog of the murine MPH gene. Gene. 159(2). 267–272. 165 indexed citations
8.
Eberlé, Frédéric, Peter Kaiser, & Michael C. Wehr. (1982). [A 17-year-old patient with dilated cardiomyopathy. Familial, pericentric inversion of chromosome 5].. PubMed. 23(9). 509–13. 2 indexed citations
9.
Eberlé, Frédéric, et al.. (1980). [Pyroderma fistulans sinifica associated with congenital alpha-1-antitrypsin deficiency].. PubMed. 31(2). 100–4. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026